MA
Mankind Pharma
MANKIND.NS·NSENew Delhi INFounded 199512,000 employees
Mid CappharmaPublicRespiratoryGI
Platform: OTC Consumer
Market Cap
$8B
All Drugs
4
Clinical Trials
5
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (MANKIND.NS)
Loading MANKIND.NS stock data...
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| MAN-5524 | MAN-5524 | Phase 2 | 1 | TYK2 | MM | ||
| Elracilimab | MAN-5609 | NDA/BLA | 1 | IL-17A | GBM | ||
| MAN-3628 | MAN-3628 | Phase 1 | 1 | FXIa | TTR AmyloidosisCLL | ||
| Capiderotide | MAN-2392 | NDA/BLA | 2 | PSMA | MMAML |
SEC Filings & Financial Documents
SEC filings are not available for NSE-listed companies.
Mankind Pharma trades on NSE (IN). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (4)